REPORT ID 6435

Global Anticoagulants Market Size, Status and Forecast 2022

Publish Date
26-Dec-17
Pages
104
Format
Electronic (PDF)

This report studies the global Anticoagulants market, analyzes and researches the Anticoagulants development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Sanofi
    Bayer
    Boehringer Ingelheim
    Johnson & Johnson
    Genentech (Roche)
    AstraZeneca
    Bristol-Myers Squibb
    Aspen
    Lilly
    Otsuka
    Pfizer
    Daiichi Sankyo
    The Medicines Company

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Platelet aggregation inhibitors (PAI)
    Low-molecular-weight Heparin (LMWH)
    Direct thrombin inhibitor (DTI)
    Direct factor Xa inhibitors (DFXa)
    Vitamin K antagonists (VKA)
    Others

Market segment by Application, Anticoagulants can be split into
    VTE
    ACS/MI
    AF
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Anticoagulants Market Size, Status and Forecast 2022
1 Industry Overview of Anticoagulants
    1.1  Anticoagulants Market Overview
        1.1.1 Anticoagulants Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Anticoagulants Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Anticoagulants Market by Type
        1.3.1 Platelet aggregation inhibitors (PAI)
        1.3.2 Low-molecular-weight Heparin (LMWH)
        1.3.3 Direct thrombin inhibitor (DTI)
        1.3.4 Direct factor Xa inhibitors (DFXa)
        1.3.5 Vitamin K antagonists (VKA)
        1.3.6 Others
    1.4 Anticoagulants Market by End Users/Application
        1.4.1 VTE
        1.4.2 ACS/MI
        1.4.3 AF
        1.4.4 Others

2 Global Anticoagulants Competition Analysis by Players
    2.1 Anticoagulants Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Sanofi
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Anticoagulants Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Bayer
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Anticoagulants Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Boehringer Ingelheim
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Anticoagulants Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Johnson & Johnson
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Anticoagulants Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Genentech (Roche)
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Anticoagulants Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 AstraZeneca
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Anticoagulants Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Bristol-Myers Squibb
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Anticoagulants Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Aspen
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Anticoagulants Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Lilly
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Anticoagulants Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Otsuka
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Anticoagulants Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Pfizer
    3.12 Daiichi Sankyo
    3.13 The Medicines Company

4 Global Anticoagulants Market Size by Type and Application (2012-2017)
    4.1 Global Anticoagulants Market Size by Type (2012-2017)
    4.2 Global Anticoagulants Market Size by Application (2012-2017)
    4.3 Potential Application of Anticoagulants in Future
    4.4 Top Consumer/End Users of Anticoagulants

5 United States Anticoagulants Development Status and Outlook
    5.1 United States Anticoagulants Market Size (2012-2017)
    5.2 United States Anticoagulants Market Size and Market Share by Players (2016 and 2017)

6 EU Anticoagulants Development Status and Outlook
    6.1 EU Anticoagulants Market Size (2012-2017)
    6.2 EU Anticoagulants Market Size and Market Share by Players (2016 and 2017)

7 Japan Anticoagulants Development Status and Outlook
    7.1 Japan Anticoagulants Market Size (2012-2017)
    7.2 Japan Anticoagulants Market Size and Market Share by Players (2016 and 2017)

8 China Anticoagulants Development Status and Outlook
    8.1 China Anticoagulants Market Size (2012-2017)
    8.2 China Anticoagulants Market Size and Market Share by Players (2016 and 2017)

9 India Anticoagulants Development Status and Outlook
    9.1 India Anticoagulants Market Size (2012-2017)
    9.2 India Anticoagulants Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Anticoagulants Development Status and Outlook
    10.1 Southeast Asia Anticoagulants Market Size (2012-2017)
    10.2 Southeast Asia Anticoagulants Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Anticoagulants Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Anticoagulants Revenue and Growth Rate (2017-2022)
        11.1.2 EU Anticoagulants Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Anticoagulants Revenue and Growth Rate (2017-2022)
        11.1.4 China Anticoagulants Revenue and Growth Rate (2017-2022)
        11.1.5 India Anticoagulants Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Anticoagulants Revenue and Growth Rate (2017-2022)
    11.2 Global Anticoagulants Market Size (Value) by Type (2017-2022)
    11.3 Global Anticoagulants Market Size by Application (2017-2022)

12 Anticoagulants Market Dynamics
    12.1 Anticoagulants Market Opportunities
    12.2 Anticoagulants Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Anticoagulants Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Anticoagulants Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source